CDC releases vaccine injury data

The Centers for Disease Control and Prevention (CDC) released new data this past Monday showing 913,268 adverse events after people received Covid vaccines between Dec. 14, 2020, and Nov. 19, 202, as reported to the Vaccine Adverse Event Reporting System (VAERS).

VAERS is the primary government-funded system for reporting adverse reaction in the United States. Every Friday, VAERS publishes vaccine injury reports received by a specific date. Reports submitted to VAERS require further investigation before a casual relationship can be confirmed.

Historically, VAERS has been shown to report only 1 percent of vaccine adverse events.

Data in the report included 19,248 deaths, an increase of 396 over the previous week, and 143,395 reports of serious injuries, including deaths, during the same time period – up by 4,269 compared with the previous week.

Excluding foreign reports to VAERS, 664,745 adverse events, including 8,898 deaths and 56,297 serious injuries were reported in the U.S between Dec. 14, 2020, and Nov. 19, 2021.

In the 5 to 11 age group, 2,093 total adverse events, including 22 rated as serious and one death, occurred prior to the authorization of Pfizer’s COVID vaccine for that age group, and 1,103 adverse events have been reported since Nov. 1.

In the 12-to-17-year-olds, there were 23,484 adverse events, including 1,239 ranked as serious and 31 reported deaths. The most recent death was a 16-year-old girl who reported died from a heart condition and multiorgan failure two days after receiving Pfizer’s COVID Vaccine. Other deaths include a 16-year-old girl who died after receiving her second dose and a 17-year-old who was reported to have died from a heart condition following her second does.

There were 59 reports of anaphylaxis among 12-to-17- year-olds where the reaction was life-threatening, required treatment or resulted in death, 560 reports of myocarditis and pericarditis (heart inflammation), and 139 reports of blood clotting disorders, with nearly all attributed to Pfizer’s vaccine.

For all age groups combined:

-19% of deaths related to cardiac disorders; 54% of those who died were male, 42% were female and the remaining did not include gender; the average age of death was 72.7.

-As of November 2021, 4,424 pregnant women reported adverse effects, including 1,390 reports of miscarriage or premature birth.

-Of the 3,197 cases of Bell’s Palsy reported, 51% were attributed to Pfizer, 41% to Moderna, and 8% to J&J.

-750 reports of Guillain-Barre Syndrome, with 41% of cases attributed to Pfizer, 30% to Moderna, and 28% to J&J.

-There were 2,149 reports of anaphylaxis where the reaction was life-threatening, requiring treatment or resulting in death.

-11,209 reports of blood clotting disorders, with 4,960 attributed to Pfizer, 4,000 to Moderna and 2,195 to J&J.

-3,209 cases of myocarditis and pericarditis with 1,999 attributed to Pfizer, 1,067 to Moderna and 133 to J&J.

In an analysis presented at the American Heart Association, Dr. Steven Gundry, a pioneer in infant heart transplant surgery, said mRNA COVID vaccines put many patients at a higher risk of a new acute coronary syndrome, such as a heart attack. The analysis concluded in part the mRNA vaccines dramatically increase inflammation on the endothelium and T cell infiltration of cardiac muscle and may account for the observations of increased thrombosis, cardiomyopathy and vascular events following vaccination.

According to the CDC, foreign reports are reports received by U.S. manufacturers from their foreign subsidiaries. Under U.S. Food and Drug Administration regulations, if a manufacturer is notified of a foreign case report that describes an event that is both serious and does not appear on the product’s labeling, the manufacturer is required to submit the report to VAERS.

Of the 8,898 U.S. death reported, 20 percent occurred within 24 hours of vaccination; 26 percent with 48 hours; and 56 percent occurred in people who experienced an onset of symptoms within 48 hours of being vaccinated.

In the U.S. 447.7 million COVID vaccine doses have been administered as of Nov. 19, including 260 million doses of Pfizer, 171 million doses of Moderna and 16 million doses of Johnson & Johnson.